1. Home » 
  2. Quarterly Results » 
  3. Ajooni Biotech Q1 Results Revenue Up 31.03% QoQ and 22.17% YoY & Net Profit Down 47.55% QoQ and Up 24.08% YoY

Ajooni Biotech Q1 Results Revenue Up 31.03% QoQ and 22.17% YoY & Net Profit Down 47.55% QoQ and Up 24.08% YoY

Ajooni Biotech Q1 Results report that the revenue was ₹2,565.85 million, up 31.03% from the previous quarter but up 22.17% from the same quarter last year and expenses increased by 36.69% QoQ and 21.28% YoY, totaling ₹2,506.92 million. 

by Ruksana

Updated Aug 21, 2024

Article continues below advertisement
Ajooni Biotech Q1 Results Revenue Up 31.03% QoQ and 22.17% YoY & Net Profit Down 47.55% QoQ and Up 24.08% YoY

Ajooni Biotech Q1 Results: Ajooni Biotech's total revenue was 25.66 crores in the first quarter of 2024. This was a significant drop of 31.03% compared to the previous quarter (41.26 crores) but an increase of 22.17% from the same period last year (21.00 crores). Ajooni Biotech's expenses for selling, general, and administrative costs were 0.57 crores, which was a huge rise of 310.90% from the previous quarter (3.49 crores) and a slight increase of 6.81% from the last year (0.54 crores). Depreciation and amortization expenses were 0.22 crores, a small decrease of 6.34% from the previous quarter and a slight increase of 6.74% from last year. 

Ajooni Biotech’s other operating expenses totaled 1.65 crores, showing a decrease of 30.20% from the previous quarter where it was -1.66 crores, and a big increase of 71.27% from last year (0.97 crores). The total operating expenses went up by 36.69% from the previous quarter to 24.92 crores but increased by 21.28% from last year (20.55 crores). Operating income dropped by 45.30% to 0.74 crores from the previous quarter but rose by 62.21% from last year (0.46 crores). 

Ajooni Biotech’s Net income before taxes fell by 58.22% to 0.63 crores from the last quarter but rose by 58.76% compared to last year (0.39 crores). The net income decreased by 47.55% to 0.48 crores from the previous quarter, while it increased by 24.08% from last year (0.39 crores). Finally, the diluted normalized earnings per share (EPS) fell by 65.97% to 0.03 from the previous quarter and by 25.82% compared to last year (0.04).

Here’s the quarterly financial summary for Ajooni Biotech for Q1:

Metric

Jun 24

Mar 23

QoQ Change

Jun 23

YoY Change

Total Revenue

25.66 crores

41.26 crores

-31.03%

21.00 crores

+22.17%

Selling/General/Admin Expenses Total

0.57 crores

3.49 crores

+310.90%

0.54 crores

+6.81%

Depreciation/Amortization

0.22 crores

0.24 crores

-6.34%

0.21 crores

+6.74%

Other Operating Expenses Total

1.65 crores

-1.66 crores

-30.20%

0.97 crores

+71.27%

Total Operating Expense

24.92 crores

40.55 crores

+36.69%

20.55 crores

+21.28%

Operating Income

0.74 crores

0.71 crores

-45.30%

0.46 crores

+62.21%

Net Income Before Taxes

0.63 crores

0.85 crores

-58.22%

0.39 crores

+58.76%

Net Income

0.48 crores

0.54 crores

-47.55%

0.39 crores

+24.08%

Diluted Normalized EPS

0.03

0.09

-65.97%

0.04

-25.82%

Source: Here 

For More Q1 Results check our Twitter Page

Visit our website for more Q1 results

Ajooni Biotech Q1 Results

Ajooni Biotech’s Q1 Results: Ajooni Biotech’s Q1 results for the quarter ended June 30, 2024, show a mix of performance metrics. The company’s revenue from operations increased to ₹2,565.85 million, up from ₹1,958.16 million in the previous quarter and ₹2,100.27 million in the same quarter last year. Other income decreased to ₹3.67 million from ₹25.68 million in the previous quarter, and the total income from operations was ₹2,569.52 million, compared to ₹1,983.84 million last quarter and ₹2,107.49 million a year ago.

Expenses were higher this quarter at ₹2,506.92 million, up from ₹1,834.01 million in the previous quarter and ₹2,068.06 million in the same quarter last year. Key expenses included costs of material consumed at ₹2,248.65 million, finance costs at ₹57.28 million, and depreciation at ₹15.02 million. The company’s profit before tax was ₹62.60 million, down from ₹149.83 million last quarter but up from ₹39.43 million a year ago.

The net profit for the quarter was ₹46.82 million, compared to ₹91.48 million last quarter and ₹40.19 million in the same quarter last year. There was a loss in other comprehensive income this quarter at ₹59.55 million, leading to a total comprehensive income of ₹151.03 million.

Here's the financial summary for the specified quarters and years:

Particulars

Quarter Ended 30.06.2024

Quarter Ended 31.03.2024

Quarter Ended 30.06.2023

Revenue from operations

2,565.85

1,958.16

2,100.27

Other income

3.67

25.68

7.22

Total income from operations

2,569.52

1,983.84

2,107.49

Cost of Material Consumed

2,248.65

1,526.39

1,902.71

Change in Inventories

(1.64)

22.01

(19.08)

Finance costs

57.28

13.94

53.63

Depreciation and amortization expenses

15.02

11.04

13.38

Payment to NSE

22.32

23.83

20.91

Other expenses

165.29

236.80

96.51

Total expenses

2,506.92

1,834.01

2,068.06

Profit/(Loss) before tax

62.60

149.83

39.43

Net Profit/(Loss) for the period/year

46.82

91.48

40.19

Other comprehensive income (loss)

-

59.55

(163)

Total comprehensive income

-

151.03

(122.58)

Article continues below advertisement
Article continues below advertisement

Ajooni Biotech Financial Metrics 

The Ajooni Biotech table shows important financial details about the company. The Market Cap is ₹121 Crore, which is the total value of all its shares. The Current Price of one share is ₹7.01. The stock reached a High of ₹8.19 and a Low of ₹3.44 in the past. 

Here's the financial information in table format:

Metric

Value

Market Cap

₹121 Crore

Current Price

₹7.01

High / Low

₹8.19 / ₹3.44

Stock P/E

54.4

Book Value

₹2.44

Dividend Yield

0.00%

ROCE

7.76%

ROE

5.12%

Face Value

₹2.00

Article continues below advertisement
Article continues below advertisement

Quarterly Results 

Ajooni Biotech's sales were Rs. 20.05 crores in December 2023, with expenses of Rs. 20.70 crores, leading to an operating loss of Rs. 0.65 crores and a negative operating profit margin of -3.24%. The company earned Rs. 1.57 crores in other income. 

Here are the transposed results for December 2023, March 2024, and June 2024:

(Figures in Rs. Crores)

Metric

Dec 2023

Mar 2024

Jun 2024

Sales

20.05

19.58

25.66

Expenses

20.70

17.99

24.70

Operating Profit

-0.65

1.59

0.96

OPM %

-3.24%

8.12%

3.74%

Other Income

1.57

0.26

0.04

Interest

0.12

0.11

0.15

Depreciation

0.21

0.24

0.22

Profit before Tax

0.59

1.50

0.63

Tax %

23.73%

38.67%

25.40%

Net Profit

0.44

0.91

0.47

EPS in Rs

0.03

0.05

0.03

Article continues below advertisement
Article continues below advertisement

About Ajooni Biotech 

Ajooni Biotech is a leading company in the animal feed industry, known for its innovation and commitment to quality. We specialize in producing high-quality animal feed, with a strong focus on safety and efficiency in our production processes. Our company is growing quickly and has become an important player in both the animal feed and aquaculture sectors.

When you choose Ajooni, you are partnering with a company that is attentive and knowledgeable about the livestock market. We aim to optimize the productivity of animals and ensure they receive a balanced diet that meets all their nutritional needs. 

Our goal is to support farmers by offering expert advice and creating tailored diet programs that help livestock grow and thrive. Our team of experts has many years of experience and is dedicated to providing the best recommendations for the health and progress of your animals. At Ajooni, we strive to be a valuable partner to all farmers, helping them achieve the best results in their farming efforts.


Ajooni Biotech Q1 Results - FAQs

1. What was Ajooni Biotech's total revenue for Q1 2024?  

Ajooni Biotech's total revenue for Q1 2024 was ₹2,565.85 million.

2. How did Ajooni Biotech's Q1 2024 revenue compare to the previous quarter?

Ajooni Biotech's Q1 2024 revenue increased from ₹1,958.16 million in the previous quarter.

3. What was the percentage drop in Ajooni Biotech’s revenue from Q4 2023 to Q1 2024?

Ajooni Biotech's revenue dropped by 31.03% from the previous quarter.

4. What were Ajooni Biotech's other income figures for Q1 2024?

Ajooni Biotech's other income for Q1 2024 was ₹3.67 million.

5. How did Ajooni Biotech's operating income in Q1 2024 compare to Q4 2023?

Ajooni Biotech’s operating income decreased by 45.30% from Q4 2023.

6. What were Ajooni Biotech's total expenses in Q1 2024?

Ajooni Biotech’s total expenses in Q1 2024 were ₹2,506.92 million.

7. How did Ajooni Biotech's net profit in Q1 2024 compare to Q4 2023?  

Ajooni Biotech’s net profit decreased by 47.55% from Q4 2023.

8. What was the increase in Ajooni Biotech’s net income before taxes in Q1 2024 compared to the same quarter last year?  

Ajooni Biotech’s net income before taxes increased by 58.76% compared to the same quarter last year.

9. How did Ajooni Biotech’s diluted normalized EPS in Q1 2024 change from Q4 2023?  

Ajooni Biotech’s diluted normalized EPS decreased by 65.97% from Q4 2023.

10. How much did Ajooni Biotech’s other operating expenses total in Q1 2024?  

Ajooni Biotech’s other operating expenses totaled ₹1.65 million in Q1 2024.

Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.